CN Patent

CN113880819B — 立他司特的制备方法及其中间体化合物

Assigned to First Affiliated Hospital of Zhejiang University School of Medicine · Expires 2024-09-20 · 2y expired

What this patent protects

本发明涉及立他司特的制备方法及其中间体化合物。具体而言，本发明涉及立他司特的合成方法、用于合成立他司特的关键中间体、其溶剂化物以及其在碱性条件下水解制备立他司特的方法。

USPTO Abstract

本发明涉及立他司特的制备方法及其中间体化合物。具体而言，本发明涉及立他司特的合成方法、用于合成立他司特的关键中间体、其溶剂化物以及其在碱性条件下水解制备立他司特的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN113880819B
Jurisdiction
CN
Classification
—
Expires
2024-09-20
Drug substance claim
No
Drug product claim
No
Assignee
First Affiliated Hospital of Zhejiang University School of Medicine
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.